GlycoMimetics Inc. (NASDAQ: GLYC)
$0.31
-0.0100 ( -3.16% ) 308.5K
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Market Data
Open
$0.31
Previous close
$0.32
Volume
308.5K
Market cap
$20.00M
Day range
$0.31 - $0.32
52 week range
$0.24 - $3.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
8-k | 8K-related | 12 | Jan 02, 2024 |
10-q | Quarterly Reports | 60 | Nov 03, 2023 |
8-k | 8K-related | 15 | Nov 03, 2023 |
4 | Insider transactions | 1 | Oct 03, 2023 |
4 | Insider transactions | 1 | Oct 03, 2023 |
4 | Insider transactions | 1 | Oct 03, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
8-k | 8K-related | 15 | Aug 02, 2023 |